BIOMAT Database Logo BIOMAT Database Logo

Efficient and highly selective covalent labeling of the estrogen receptor with [3H]tamoxifen aziridine. 1983

J A Katzenellenbogen, and K E Carlson, and D F Heiman, and D W Robertson, and L L Wei, and B S Katzenellenbogen

UI MeSH Term Description Entries
D007553 Isotope Labeling Techniques for labeling a substance with a stable or radioactive isotope. It is not used for articles involving labeled substances unless the methods of labeling are substantively discussed. Tracers that may be labeled include chemical substances, cells, or microorganisms. Isotope Labeling, Stable,Isotope-Coded Affinity Tagging,Isotopically-Coded Affinity Tagging,Affinity Tagging, Isotope-Coded,Affinity Tagging, Isotopically-Coded,Isotope Coded Affinity Tagging,Labeling, Isotope,Labeling, Stable Isotope,Stable Isotope Labeling,Tagging, Isotope-Coded Affinity,Tagging, Isotopically-Coded Affinity
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular
D011960 Receptors, Estrogen Cytoplasmic proteins that bind estrogens and migrate to the nucleus where they regulate DNA transcription. Evaluation of the state of estrogen receptors in breast cancer patients has become clinically important. Estrogen Receptor,Estrogen Receptors,Estrogen Nuclear Receptor,Estrogen Receptor Type I,Estrogen Receptor Type II,Estrogen Receptors Type I,Estrogen Receptors Type II,Receptor, Estrogen Nuclear,Receptors, Estrogen, Type I,Receptors, Estrogen, Type II,Nuclear Receptor, Estrogen,Receptor, Estrogen
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003600 Cytosol Intracellular fluid from the cytoplasm after removal of ORGANELLES and other insoluble cytoplasmic components. Cytosols
D004958 Estradiol The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids. 17 beta-Estradiol,Estradiol-17 beta,Oestradiol,17 beta-Oestradiol,Aerodiol,Delestrogen,Estrace,Estraderm TTS,Estradiol Anhydrous,Estradiol Hemihydrate,Estradiol Hemihydrate, (17 alpha)-Isomer,Estradiol Monohydrate,Estradiol Valerate,Estradiol Valeriante,Estradiol, (+-)-Isomer,Estradiol, (-)-Isomer,Estradiol, (16 alpha,17 alpha)-Isomer,Estradiol, (16 alpha,17 beta)-Isomer,Estradiol, (17-alpha)-Isomer,Estradiol, (8 alpha,17 beta)-(+-)-Isomer,Estradiol, (8 alpha,17 beta)-Isomer,Estradiol, (9 beta,17 alpha)-Isomer,Estradiol, (9 beta,17 beta)-Isomer,Estradiol, Monosodium Salt,Estradiol, Sodium Salt,Estradiol-17 alpha,Estradiol-17beta,Ovocyclin,Progynon-Depot,Progynova,Vivelle,17 beta Estradiol,17 beta Oestradiol,Estradiol 17 alpha,Estradiol 17 beta,Estradiol 17beta,Progynon Depot
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

J A Katzenellenbogen, and K E Carlson, and D F Heiman, and D W Robertson, and L L Wei, and B S Katzenellenbogen
Localization of the estrogen receptor in uterine cells by affinity labeling with [3H]tamoxifen aziridine.
July 1991, The Journal of steroid biochemistry and molecular biology,
J A Katzenellenbogen, and K E Carlson, and D F Heiman, and D W Robertson, and L L Wei, and B S Katzenellenbogen
Identification of cysteine 530 as the covalent attachment site of an affinity-labeling estrogen (ketononestrol aziridine) and antiestrogen (tamoxifen aziridine) in the human estrogen receptor.
October 1989, The Journal of biological chemistry,
J A Katzenellenbogen, and K E Carlson, and D F Heiman, and D W Robertson, and L L Wei, and B S Katzenellenbogen
Ketononestrol aziridine, an agonistic estrogen receptor affinity label: study of its bioactivity and estrogen receptor covalent labeling.
August 1987, Endocrinology,
J A Katzenellenbogen, and K E Carlson, and D F Heiman, and D W Robertson, and L L Wei, and B S Katzenellenbogen
Tamoxifen aziridine labeling of the estrogen receptor-potential utility in detecting biologically aggressive breast tumors.
January 1996, Breast cancer research and treatment,
J A Katzenellenbogen, and K E Carlson, and D F Heiman, and D W Robertson, and L L Wei, and B S Katzenellenbogen
The interaction site for tamoxifen aziridine with the bovine estrogen receptor.
August 1989, The Journal of biological chemistry,
J A Katzenellenbogen, and K E Carlson, and D F Heiman, and D W Robertson, and L L Wei, and B S Katzenellenbogen
A comparison of 11 beta-chloromethylestradiol and tamoxifen aziridine as affinity labeling reagents for estrogen receptors.
January 1988, Steroids,
J A Katzenellenbogen, and K E Carlson, and D F Heiman, and D W Robertson, and L L Wei, and B S Katzenellenbogen
Dissociation of 4-hydroxytamoxifen, but not estradiol or tamoxifen aziridine, from the estrogen receptor as the receptor binds estrogen response element DNA.
January 1996, The Journal of steroid biochemistry and molecular biology,
J A Katzenellenbogen, and K E Carlson, and D F Heiman, and D W Robertson, and L L Wei, and B S Katzenellenbogen
Anti-thrombotic effects of selective estrogen receptor modulator tamoxifen.
October 2011, Thrombosis and haemostasis,
J A Katzenellenbogen, and K E Carlson, and D F Heiman, and D W Robertson, and L L Wei, and B S Katzenellenbogen
4-iodotamoxifen aziridine, a new affinity labeling agent for the rapid detection of estrogen receptor isoforms.
October 1998, The Journal of steroid biochemistry and molecular biology,
J A Katzenellenbogen, and K E Carlson, and D F Heiman, and D W Robertson, and L L Wei, and B S Katzenellenbogen
Tamoxifen Resistance Trumped and Oral Selective Estrogen Receptor Degraders Arrive.
August 2018, Clinical cancer research : an official journal of the American Association for Cancer Research,
Copied contents to your clipboard!